AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, operates within the medical devices industry, providing essential home medical equipment and services across the United States. Headquartered in..
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is garnering attention in the biotech sector, particularly due to its impressive 25.2% revenue growth and a strong consensus from analysts. With a market cap..
For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) presents a compelling case for consideration. As a global biopharmaceutical company, Amneal specializes in the development, manufacturing,..
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent name in the biotechnology sector, has captured investor attention with its high potential upside of 86.95%, as indicated by current analyst ratings. This..
Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is capturing the attention of growth-oriented investors due to its potential upside of 66.34%. With its current stock price..
Ardent Health, Inc. (NASDAQ: ARDT) is catching the attention of investors, boasting a robust 48.52% potential upside, as it currently trades at $13.68. Situated in the ever-dynamic healthcare sector, Ardent..
For investors eyeing the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a unique opportunity within the medical devices industry. Based in San Jose, California, PROCEPT BioRobotics has carved out..
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to tackling chronic diseases. Based in South San Francisco, the..
Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, operates within the health information services industry, providing innovative medication management solutions to healthcare systems and pharmacies in the..
Investors with a keen eye on the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing opportunity, given its significant potential upside of 121.81%. This late-stage clinical biopharmaceutical..
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is a prominent player in the rapidly evolving biotechnology sector, leveraging cutting-edge technological advancements to redefine drug discovery. Headquartered in Salt Lake City, Utah, this..
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is turning heads in the healthcare sector with its promising pipeline of treatments for diseases with unmet needs, particularly in the cardiovascular domain. With a..
Travere Therapeutics, Inc. (NASDAQ: TVTX) has captured investor attention with its impressive potential upside of 133.30%, driven by its focused endeavors in addressing rare kidney and metabolic diseases. As a..
Investors looking for opportunities in the biotechnology sector may want to keep a close watch on Vera Therapeutics, Inc. (VERA). As a clinical-stage biotech firm, Vera Therapeutics focuses on developing..
Privia Health Group, Inc. (PRVA), a compelling player in the healthcare sector, operates as a national physician-enablement company in the United States. With a market capitalization of $2.83 billion, Privia..
Celldex Therapeutics, Inc. (NASDAQ: CLDX), a cutting-edge biopharmaceutical company headquartered in Hampton, New Jersey, is making waves in the biotechnology sector. Specializing in the development of therapeutic antibodies targeting severe..
BioCryst Pharmaceuticals, Inc. (BCRX), a prominent player in the healthcare sector, focuses on developing innovative treatments for rare diseases. With a current market capitalization of $2.32 billion, this Durham, North..
Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, has caught the attention of investors with its ambitious vaccine development pipeline and a striking potential upside of..
Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector with its innovative approach to treating serious hematologic diseases. As a clinical-stage biopharmaceutical company, Disc Medicine is dedicated..
Janux Therapeutics, Inc. (NASDAQ: JANX), a pioneering player in the biotechnology sector, has captured the attention of investors with its promising pipeline of cancer immunotherapies. With a market capitalization of..
